Evidence map›Paper›PMID 30137391›Full record

ArticleJournal of radiation research2019

Japanese structure survey of radiation oncology in 2010.

Hodaka Numasaki, Teruki Teshima, Tetsuo Nishimura, Keizo Akuta, Yutaka Ando, Hiroshi Ikeda, Norihiko Kamikonya, Masahiko Koizumi, Tomonari Sasaki, Kenji Sekiguchi and 8 more

Abstract read
In one paragraph

Article in Journal of radiation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Hodaka NumasakiDepartment of Functional Diagnostic Science, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, Japan.
Teruki TeshimaDepartment of Radiation Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-ku, Osaka-shi, Osaka, Japan.
Tetsuo NishimuraDivision of Radiation Oncology, Shizuoka Cancer Center Hospital, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, Japan.
Keizo AkutaDepartment of Radiology, Japanese Red Cross Otsu Hospital, 1-1-35 Nagara, Otsu-shi, Siga, Japan.
Yutaka AndoDepartment of Radiation Oncology, Saitama Medical Center, 4-9-3 Kitaurawa, Urawa-ku, Saitama-shi, Saitama, Japan.
Hiroshi IkedaDepartment of Radiation Oncology, Sakai City Medical Center, 1-1-1 Ebaraji-cho, Nishi-ku, Sakai-shi, Osaka, Japan.
Norihiko KamikonyaDepartment of Radiology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya-shi, Hyogo, Japan.
Masahiko KoizumiDepartment of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita-shi, Osaka, Japan.
Tomonari SasakiDivision of Medical Quantum Science, Department of Health Sciences, Kyushu University Faculty of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka, Japan.
Kenji SekiguchiSonoda-kai Radiation Oncology Clinic, 3-4-19 Hokima, Adachi-ku, Tokyo, Japan.
Masao TagoDepartment of Radiology, Teikyo University Mizonokuchi Hospital, 5-1-1 Futako, Takatsu, Kawasaki-shi, Kanagawa, Japan.
Atsuro TeraharaDepartment of Radiology, Toho University Omori Medical Center, 6-11-1 Omori-nishi, Ota-ku, Tokyo, Japan.
Katsumasa NakamuraDepartment of Radiation Oncology, Hamamatsu University Hospital, 1-20-1 Handayama, Higashi-ku, Hamamatsu-shi, Shizuoka, Japan.
Masamichi NishioHokkaido Cancer Center, 2-3-54 Kikusui 4jyo, Shiraishi-ku, Sapporo-shi, Hokkaido, Japan.
Masao MurakamiSouthern TOHOKU Proton Therapy Center, 172-7 Yatsuyamada, Koriyama-shi, Fukushima, Japan.
Yoshimasa MoriDepartment of Radiology and Radiation Oncology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute-shi, Aichi, Japan.
Kazuhiko OgawaDepartment of Radiation Oncology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita-shi, Osaka, Japan.
Japanese Society for Radiation Oncology Database Committee

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the evolving structure of radiation oncology in Japan in terms of equipment, personnel, patient load, and geographic distribution to identify and overcome any existing limitations. From March 2011 to June 2013, the Japanese Society for Radiation Oncology conducted a questionnaire based on the Japanese national structure survey of radiation oncology in 2010. Data were analyzed based on the institutional stratification by the annual number of new patients treated with radiotherapy per institution. The estimated annual numbers of new and total (new plus repeat) patients treated with radiation were 211 000 and 251 000, respectively. Additionally, the estimated cancer incidence was 805 236 cases, with ~26.2% of all newly diagnosed patients being treated with radiation. The types and numbers of treatment devices actually used included linear accelerator (LINAC; n = 829), telecobalt (n = 9), Gamma Knife (n = 46), 60Co remote afterloading system (RALS; n = 28), and 192Ir RALS (n = 131). The LINAC system used dual-energy functions in 586 units, three-dimensional conformal radiotherapy functions in 663, and intensity-modulated radiotherapy (IMRT) functions in 337. There were 564 JASTRO-certified radiation oncologists, 959.2 full-time equivalent (FTE) radiation oncologists, 1841.3 FTE radiotherapy technologists, 131.3 FTE medical physicists, 121.5 FTE radiotherapy quality managers, and 649.6 FTE nurses. The frequency of IMRT use significantly increased during this year. To conclude, although there was a shortage of personnel in 2010, the Japanese structure of radiation oncology has clearly improved in terms of equipment and utility.

Indexed as

Surveys and QuestionnairesHumansJapanNeoplasmsParticle AcceleratorsRadiation OncologyRadiotherapy

Identifiers

PMID30137391
PMCPMC6373681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.